The use of Shiga-like toxin 1 in cancer therapy
- 14 June 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 39 (1-2) , 99-106
- https://doi.org/10.1016/s1040-8428(01)00126-3
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Role of the Disulfide Bond in Shiga Toxin A-chain for Toxin Entry into CellsJournal of Biological Chemistry, 1997
- Insertion and Orientation of a Synthetic Peptide Representing the C-Terminus of the A1 Domain of Shiga Toxin into Phospholipid MembranesBiochemistry, 1996
- Special Section: Autologous Stem Cell Tranplantations in Solid Tumours: Autologous Stem Cell Transplants in LymphomasAnnals of Medicine, 1996
- Autologous bone marrow transplantationCurrent Opinion in Oncology, 1993
- Role of Bacterial Cytotoxins in Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic PurpuraAnnual Review of Medicine, 1993
- Mutations affecting the activity of the Shiga-like toxin I A-chainBiochemistry, 1992
- Neutral glycosphingolipid expression in B-cell neoplasmsInternational Journal of Cancer, 1991
- CD77: an antigen of germinal center B cells entering apoptosisEuropean Journal of Immunology, 1991
- Autologous Bone Marrow TransplantationAnnual Review of Medicine, 1989
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988